Author:
Millar Helen L.,Salloum Ihsan M.
Publisher
Springer International Publishing
Reference38 articles.
1. Bagdy G, Juhasz G. Biomarkers for personalised treatment in psychiatric diseases. Expert Opinion; Informa Healthcare. Med Dian. 2013;7(5):417–422.
2. Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiolgy of multimorbidity and implications for healthcare, research, and medical education: a cross sectional study. Lancet. 2012;380(9836):37–43. doi: 10.1016/S0140-6736(12)60240-2 .
3. Citrome LL, et al. Risk of treatment/emergent diabetes mellitus in patients receiving antipsychotics. Ann Pharmacother. 2007;41:1593–603.
4. Cloninger CR, Salloum IM, Mezzich JE. The dynamic origins of positive health and wellbeing. Int J Person Centered Med. 2012;2(2):179–87.
5. Danaei G, Finucane MM, Lu Y, Singh GM, Cowan MJ, Paciorek CJ, et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet. 2011;378(9785):31–40.